About clinical trials
Clinical trials are research projects that involve volunteers testing new ways to detect, diagnose or treat health conditions. This may include testing new medicines, devices or approaches to care.
These trials often lead to real improvements in patient health outcomes both now and in the future.
Learn more about clinical trials in NSW as well as Australian clinical trials, including the strict safety and ethical standards they need to follow.
Clinical Trial Research Centre
The REN Clinical Trial Research Centre (CTRC) supports high-quality clinical trials and research across Western Sydney Local Health District (WSLHD). We focus on:
- Supporting pharmaceutical-sponsored clinical trials
- Building collaborative research partnerships
- Ensuring patient-centred approaches.
What we offer
The CTRC provides facilities and guidance for both experienced and new researchers.
- Novice and start-up researchers can access study coordinators for support with start-up, patient recruitment, data collection and other study activities. Services are available on a reimbursement basis.
- Facilities include:
- Dedicated space for participant visits
- Blood collection (venepuncture)
- Sample processing
- Storage.
The CTRC provides overall support and governance for clinical research across Western Sydney LHD. Our team:
- Grows and manages research capacity and capability in WSLHD
- Develops and maintains partnerships to position WSLHD as a trusted clinical trials provider
- Creates and manages service partnership agreements with industry and research partners.
How we support researchers
We provide advice and resources at every stage of research – from concept development through to approval, implementation, reporting and publication. This includes:
- Help with protocol writing and identifying the right application type
- Guidance through the research approval process, including support to prepare Human Research Ethics Committee (HREC) and Research Governance applications in REGIS
- Connecting pharmaceutical industry partners with key Western Sydney LHD contacts to conduct clinical trials
- Access to International Council for Harmonisation Good Clinical Practice (ICH GCP) training to help researchers understand their roles and responsibilities
- Financial management support, including help with budget negotiation
- Strong links with NSW Health Office for Health and Medical Research (OHMR)
- Interpreter bookings for research participants from Culturally and Linguistically Diverse (CALD) backgrounds.
| Name | Title | Phone | |
|---|---|---|---|
| Haleh Shahidipour | Clinical Research Facility Centre Manager | (02) 8890 9945 | WSLHD-REN-CTRC@health.nsw.gov.au |
| Allison Sigmund | WSLHD Clinical Research Support Manager | (02) 8890 4318 | allison.sigmund@health.nsw.gov.au |
| Jack Giannini | Clinical Trials Management Systems Administrator | (02) 8890 4336 | WSLHD-REN-CTRC@health.nsw.gov.au |
| Jessica Kim | Senior Clinical Trials Coordinator | (02) 8890 3413 | WSLHD-clinicalresearchsupportunit@health.nsw.gov.au |
| Taiba Shafaieeshaq | Senior Clinical Trials Coordinator | (02) 8890 7491 | WSLHD-clinicalresearchsupportunit@health.nsw.gov.au |
| Anum Faruki | Clinical Trials Assistant | (02) 88904336 | WSLHD-REN-CTRC@health.nsw.gov.au |
We run a wide range of clinical trial research across Western Sydney LHD. We have dedicated support structures in place for researchers who are involved in these clinical trial activities. Our support centres include:
- Clinical Research Centre (CRC) at Westmead Hospital: This centre supports pharmaceutical-sponsored and collaborative clinical trials, offering services from study start-up and patient recruitment to data collection and coordination. Discover more about how the Clinical Research Centre supports clinical trials.
- Clinical Research Support Unit (CRSU): The CRSU provides support with preparing governance (HREC) using REGIS and oversight of clinical research district-wide. It helps researchers navigate from initial concept and approvals through to implementation, reporting, and publication. Find out more about the Clinical Research Support Unit.
- Western Sydney LHD Research Office: The Research Office is a central coordination point for all clinical trial research activities, including ethics and governance support (HREC), safety, consent requirements and fees. Learn more about the Research Office.
WSLHD specialises in clinical trials and research in the following areas:
- Allied health
- Anaesthetics and surgery
- Breast cancer
- Cardiology
- Dermatology
- Diabetes and endocrine disorders
- Emergency
- Gastrointestinal and liver disorders
- Genetics medicine
- Gynaecological oncology
- Haematology
- Immunology
- Infectious diseases
- Intensive care
- Medical oncology
- Mental health
- Midwifery and nursing
- Neurology
- Orthopaedics
- Palliative care
- Radiation oncology
- Renal
- Respiratory and sleep disorders
- Rheumatology
- Women and newborn health.
Western Sydney LHD is responsible for monitoring all research it approves through its governance processes. The Clinical Research Support Unit (CRSU) manages this by running the authorisation and booking system.
You can submit your monitors privacy agreement, photo ID and patient list at REDCap privacy agreement.
Health care interpreters must be used in all clinical trial and research situations where clear communication is essential for people who are not fluent in English, including people who are hearing impaired.
Working with interpreters helps health professionals meet their duty of care. It also ensures the highest possible quality of communication when a language other than English is involved.
If a NSW Health Care Interpreter Service (HCIS) is needed for discussions about a clinical trial or research, you can book the interpreter through the Clinical Research Support Unit (CRSU).
For pharmaceutical-sponsored clinical trials and research, HCIS is provided on a fee-for-service basis.
More details are available in the CRSU Use of Health Care Interpreter Service for Clinical Trials and Research Standard Operating Procedure (SOP) (PDF 195.01KB).
The CRSU will contact HCIS to arrange the booking and will confirm the details with the research team.
When research activities need the support from a commercial company for example the use of investigational product, radiology or pathology services, an agreement will need to be in place before that support is provided.
All agreements must be made through the CRSU who will provide help in preparing the SLA.
For help with your SLA contact WSLHD-clinicalresearchsupportunit@health.nsw.gov.au.
When this has been signed by the service provider it is submitted as part of the REGIS application to Western Sydney LHD Research Governance for approval.
If confidential information is to be exchanged with an external entity, a Confidentiality Disclosure Agreement (CDA) is needed.
This agreement obligates the external entity or individual to uphold the confidentiality of the shared information, restricting its use to the specified purposes only. All CDAs must be signed by the Director of Research in Western Sydney LHD.
What is CTMS?
The Clinical Trials Management System (CTMS) is a shared online repository for clinical trials management which organises and stores all of NSW Health’s clinical trial operational data in one location. It allows trial staff to manage participants and recruitment, review budgets and forecasting, and track grants, invoices and funding milestones. The system supports public hospitals and health services to meet accreditation obligations under the National Clinical Trials Governance Framework (NCTGF).
Inclusion of new trials on CTMS became mandatory in September of 2023 as per the NSW Health Office for Health and Medical Research.
Who needs to use CTMS?
Any research staff with a clinical trial that meets all of the following criteria MUST be entered into CTMS:
- Meets the World Health Organisation (WHO) definition of a clinical trial which involves prospectively assigning human participants or groups to health-related interventions to evaluate the effects on health outcomes. Interventions include, but are not restricted to drugs, surgical procedures, devices, behavioural treatments and preventive care (WHO, 2020);
- The clinical trial is conducted at a NSW Health public facility or service, by a NSW Health employee or contingent worker, requiring a SSA within that District;
- SSA authorisation is received on, or after, September 1st, 2023; and
- The clinical trial captures individual patient data.
How do I register for CTMS and how do I access it?
You can register here for access CTMS.
To log into CTMS please visit the NSW Statewide Clinical Trial Management System SharePoint.
CTMS Contact
Jack Giannini
Clinical Trials Management Systems Administrator
Phone: (02) 8890 4336
Email: WSLHD-clinicalresearchsupportunit@health.nsw.gov.au
The International Air Transport Authority (IATA) Dangerous Goods regulations is to provide consistent technical requirements for the transport of dangerous goods across Australia.
If you are responsible for packing or supervising an individual who packs dangerous goods for transport by air including:
- Enclosing the goods in packaging
- Marking or labelling the consignment or
- Preparing a shipper’s declaration.
You are required by both the IATA and Civil Aviation Safety Authority (CASA) to make sure that you have received the appropriate dangerous goods training on an approved course certified by CASA.
For information on dangerous goods training contact the CRSU at WSLHD-clinicalresearchsupportunit@health.nsw.gov.au
Find a clinical trial

Search for Western Sydney Local Health District in the Australian New Zealand Clinical Trials Registry.
Your doctor may suggest one or you may hear about it from someone you know or a member of a support group.
If you find a clinical trial that you would like to volunteer for, you’ll need to find out if you are eligible to participate and talk to your doctor about it.
Researcher training
ICH Good Clinical Practice (GCP) is an international standard for the design, conduct, documentation, and reporting of clinical trials and research and is essential for all researchers.
Find out about the ICH GCP along with the latest training schedule.
All researchers who work at the site level must follow GCP, including:
- Principal and sub-investigators
- Research nurses
- Coordinators and data managers
- Research assistants
- Pharmacists
- Other clinical trial staff.
The Therapeutic Goods Administration (TGA) in Australia has adopted the International Council for Harmonisation (ICH) GCP guidelines and other global standards. These work alongside the National Statement on Ethical Conduct in Human Research.
You can read more about how GCP applies to clinical research on the Australian Clinical Trials website.
Free TransCelerate-accredited GCP is available for WSLHD and Sydney Health Partners staff
The training is:
recognised by clinical trial sponsors
aligned with ICH GCP Investigator Site Personnel Training standards.
Course options
You can choose from 2 face-to-face courses:
Introduction to GCP
- For new researchers or staff who have not completed full training before.
- Duration: 4 hours.
Refresher GCP
- For experienced researchers and staff who already hold GCP certification.
- Duration: 2 hours.
What you will learn
Both courses cover 5 modules:
- GCP background and why it is needed.
- Study set up, roles and responsibilities, approvals and essential documents.
- Informed consent.
- Case report forms, source documents and source data.
- Safety reporting.
Contact the Clinical Research Support Unit to book a course at: WSLHD-ClinicalResearchSupportUnit@health.nsw.gov.au
The International Council for Harmonisation (ICH) adopted the updated Good Clinical Practice guideline E6(R3) on 6 January 2025.
In Australia, the Therapeutic Goods Administration (TGA) must endorse the new guideline before it can be used. The TGA will soon open public consultation on its website and social media channels. This will include details about transition timeframes. There will be opportunities to provide feedback on E6(R3) and the proposed TGA changes to align with Australian regulations.
Until the TGA adopts E6(R3), the current version - E6(R2) still applies to clinical trials of medicines and biologicals under the Clinical Trial Notification and Clinical Trial Approval schemes.
In line with other NSW Health organisations, training on E6(R3) will not begin until the TGA has formally endorsed it.
Western Sydney LHD Good Clinical Practice trainers have already received training in E6(R3). When they deliver E6(R2) training, they will highlight where changes are coming. More information will be shared once the TGA completes its consultation and endorsement process.
If you have any questions, you can contact the Clinical Research Support Unit at: WSLHD-ClinicalResearchSupportUnit@health.nsw.gov.au
| Course type | Day | Dates | Time | Location |
|---|---|---|---|---|
| Full GCP | Wednesday | 10 December | 9am - 1pm | Hybrid - Blacktown MS Teams |
| Refresher GCP | Tuesday | 16 December | 11am - 12:30pm | Hybrid - Westmead MS Teams |
For more training opportunities contact the Clinical Research Support Unit at: wslhd-crsu@health.nsw.gov.au
